edited by Uma Lakshmipathy
Emerging Technology Platforms For Stem Cells focuses on practical applications for using adult and embryonic stem cells in the pharmaceutical development process.
Emerging Technology Platforms For Stem Cells emphasizes new technologies to help overcome the bottlenecks in developing stem cells as therapeutic agents.
Contents
- Derivation methods for human embryonic stem cells: Past, present & future
- Isolation of human ESCs from various stages of the human embryo
- Derivation of stem cells from epiblasts
- Derivation of Embryonic Stem Cells from Parthenogenetic Eggs
- Reprogramming Developmental Potential
- Adult stem cells and their role in endogenous tissue repair
- Greater differentiation potential of adult stem cells
- Cancer stem cells
- Large scale production of adult stem cells for clinical use
- Genetic and epigenetic features of stem cells
- Identification of signaling pathways involved during differentiation
- Media and extracellular matrix requirements for large scale ESC growth
- Automated method for culturing ES cells
- Quantitative 2D Imaging of Human Embryonic Stem Cells
- Nanobiotechonology for stem cell culture and Maintenance
- Engineering Microenvironments to Control Stem Cell Functions
- Improved lentiviral gene delivery tools for stem cells
- Sleeping Beauty-mediated Transposition in Stem Cells
- PhiC31 Integrase for Modification of Stem Cells
- Cell Engineering using Integrase and Recombinase systems
- Human Embryonic Stem Cell-derived cardiomyocytes for cell therapy and drug discovery
- Human Embryonic Stem Cells in Drug discovery
- Characterization and Culturing of Adipose-Derived Precursor Cells
- Bringing Mesenchymal stem cells to clinic
Index